News | May 28, 2008

Curlin CMS, PainSmart Infusion Pumps Should Undergo Immediate Testing to Prevent Overinfusion

May 29, 2008 - ECRI Institute, an independent, nonprofit organization that researches the best approaches to improving patient care, has issued a priority medical device alert recommending immediate volume testing of Curlin Medical’s 2000 CMS, 4000 CMS, 6000 CMS, and PainSmart series pumps for potential overinfusion of medications.

Engineers at ECRI Institute’s medical device laboratory tested Curlin pumps and found that doors on the pumps do not fully compress tubing during operation, which may result in intermittent gravity flow, releasing medication too quickly. ECRI Institute emphasizes that there may be no visible indication that a pump permits gravity flow and that volume testing is the only way to determine whether a particular pump has a door problem.

“In addition to immediately identifying and testing all Curlin pumps, we recommend instituting a policy of regular volume testing every three months,” says Eric S. Sacks, director, healthcare product alerts, ECRI Institute.

Alerts are issued weekly in Health Devices Alerts, a component of membership in ECRI Institute’s Health Devices System, Health Devices Gold, and SELECTplus programs. Each alert includes a priority level, problem summary, perspectives, and recommendations for responding to the problem.

For more information: www.curlinmedical.com, www.ecri.org

Related Content

statins, heart scan, CT scan
News | March 25, 2014
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it...
News | September 30, 2013
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow...
Feature | February 21, 2013
  Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how...
Feature | April 02, 2012
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most...
News | November 18, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic...
News | October 21, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete...
News | October 05, 2009
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine...
News | July 10, 2009
July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way...
News | April 06, 2009
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (...
News | June 16, 2008
June 17, 2008 - One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic
Overlay Init